A novel interplay between PRC2 and miR‐3189 regulates epithelial–mesenchymal transition (EMT) via modulating COL6A2 in glioblastoma
- 11 June 2024
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 239 (8)
Abstract
Recent studies have shed light on disrupted collagen signaling in Gliomas, yet the regulatory landscape remains largely unexplored. This study enquired into the role of polycomb repressive complex‐2 (PRC2)‐mediated H3K27me3 modification, a key epigenetic factor in glioma. Using in‐house data, we identified miRNAs downregulated in glioblastoma (GBM) with the potential to regulate Collagen VI family genes. Notably, miR‐3189 emerged as a prime PRC2 target. Its expression was significantly downregulated in Indian GBM patients as well as other glioma cohorts. Mechanistic insights, involving Luciferase assays, mutagenesis, and Western blot analysis, confirmed direct targeting of Collagen VI member COL6A2 by miR‐3189‐3p. Functional assays demonstrated that miR‐3189‐3p restrained GBM malignancy by inhibiting proliferation, migration, and epithelial–mesenchymal transition (EMT). Conversely, COL6A2 overexpressed in GBM patients, countered miR‐3189, and promoted the malignant phenotype. Gene set enrichment analysis highlighted EMT enrichment in GBM patients with elevated COL6A2 expression, carrying prognostic implications. This study uncovers intricate interactions between two epigenetic regulators—H3K27me3 and miR‐3189—working synergistically to modulate Collagen VI gene; thus, influencing the malignancy of GBM. Targeting this H3K27me3|miR‐3189‐3p|COL6A2 axis presents a potential therapeutic avenue against GBM.Keywords
This publication has 60 references indexed in Scilit:
- Collagen VI sustains cell stemness and chemotherapy resistance in glioblastomaCellular and Molecular Life Sciences, 2023
- Role of COL6A2 in malignant progression and temozolomide resistance of gliomaCellular Signalling, 2022
- Polycomb complex mediated epigenetic reprogramming alters TGF‐β signaling via a novel EZH2/miR‐490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomasInternational Journal of Cancer, 2019
- Collagen VI disorders: Insights on form and function in the extracellular matrix and beyondMatrix Biology, 2018
- Role of Collagen Matrix in Tumor Angiogenesis and Glioblastoma Multiforme ProgressionThe American Journal of Pathology, 2013
- Circulating microRNAs in plasma as early detection markers for breast cancerInternational Journal of Cancer, 2012
- miRWalk – Database: Prediction of possible miRNA binding sites by “walking” the genes of three genomesJournal of Biomedical Informatics, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic DifferentiationCancer Cell, 2010
- S-adenosylhomocysteine hydrolase inhibition by 3-deazaneplanocin A analogues induces anti-cancer effects in breast cancer cell lines and synergy with both histone deacetylase and HER2 inhibitionBreast Cancer Research and Treatment, 2010